* Surmodics Inc SRDX.OQ reported a quarterly adjusted loss
of 13
cents per share for the quarter ended in December. The mean
expectation of four analysts for the quarter was for a loss
of 31 cents per share.
* Revenue rose 3.2% to $23.00 million from a year ago;
analysts
expected $23.71 million.
* Surmodics Inc's reported EPS for the quarter was a loss
of 20
cents.
* The mean earnings estimate of analysts had fallen by
about 1,153.3% in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Surmodics Inc shares had fallen by 4.3% this quarter.
* The company reported a quarterly loss of $2.81 million.
* Wall Street's median 12-month price target for Surmodics
Inc is
$72.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated February 3 at 04:52 p.m.
All figures in US dollars unless otherwise stated